Detailed answers about ARISIEN PHARMACEUTICALS & RESEARCH LIMITED, including incorporation, status, business activity, and accounts information.
When was ARISIEN PHARMACEUTICALS & RESEARCH LIMITED founded?
ARISIEN PHARMACEUTICALS & RESEARCH LIMITED was officially incorporated on 1 September 2025 and is registered under company number SC861084. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ARISIEN PHARMACEUTICALS & RESEARCH LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ARISIEN PHARMACEUTICALS & RESEARCH LIMITED?
ARISIEN PHARMACEUTICALS & RESEARCH LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ARISIEN PHARMACEUTICALS & RESEARCH LIMITED do?
ARISIEN PHARMACEUTICALS & RESEARCH LIMITED operates in the following sector: 46460 - Wholesale of pharmaceutical goods. This provides insight into the company's primary business activity and industry focus.
What is ARISIEN PHARMACEUTICALS & RESEARCH LIMITED's registered address?
The registered office address of ARISIEN PHARMACEUTICALS & RESEARCH LIMITED is 22 PRIORWOOD ROAD, NEWTON MEARNS, UNITED KINGDOM, G77 6ZZ. This is the official address filed with Companies House for legal and statutory correspondence.
Is ARISIEN PHARMACEUTICALS & RESEARCH LIMITED financially stable?
Financial accounts for ARISIEN PHARMACEUTICALS & RESEARCH LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.